Thursday, April 24, 2014 12:59:47 PM
what insults?..to whom?..
"There are ALWAYS other options to explore,so let's not act oblivious to the fact. "
exploring other options?...the exploring has been done for years...but sure lets pretend exploring is accomplishing something...
"I believe it boiled down to the question of what Kim was willing to give up,,in order to keep his promise to the shareholders,while also considering the business model. "
i believe it boils down to kim desperately needing a legitimate reputable financial institution willing to assist in financing kblb...and he cant find one...and i believe the reason is is that when they see what hes got and where hes at with it and how much he needs and how long there is to go etc etc coupled with the fact that hes a one man show running a tiny pink sheet company with big dreams, they just arent interested...and yes im sure the terms under those circumstances would be very hard for kim to swallow...aint no doubt about that...
"Certain sacrifices had to be made,for the "greater good."
face it...he cant get financing...the "greater good" would be very well served with legit financing...
"Tell me what SPECIFICALLY CSC is doing (or has done) to KBLB to warrant such a statement. "
they are a disreputable company run by disreputable people...they should have been jettisoned asap...kim cant...he has no choice...
"Who are paid to write a lot of articles."
no kidding...what about it?...that doesnt change a thing i said...
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM